AI-generated summary
The authors report a randomized, sham-controlled, double-blind trial of intraoral photobiomodulation in 30 women with myogenous temporomandibular disorder. Active treatment was associated with significantly greater reductions in pain and improved functioning than sham, with no significant difference in mandibular range of motion.
- Participants
- 30
- Who or what was studied
- Women with myogenous temporomandibular disorder diagnosed by Research Diagnostic Criteria for Temporomandibular Disorders
- Wavelengths
- 905, 640, 875 nm
- Limits stated in the abstract
- The abstract reports only a single trial of 30 women, so the findings may not generalize to other populations or longer-term outcomes.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 905 nm, 640 nm, 875 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Sham, Laser, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.